1042 related articles for article (PubMed ID: 16874466)
1. Could activated tissue remodeling be considered as early marker for progressive valve degeneration? Comparative analysis of checkpoint and ECM remodeling gene expression in native degenerating aortic valves and after bioprosthetic replacement.
Yeghiazaryan K; Skowasch D; Bauriedel G; Schild H; Golubnitschaja O
Amino Acids; 2007 Jan; 32(1):109-14. PubMed ID: 16874466
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory regulation of extracellular matrix remodeling in calcific aortic valve stenosis.
Kaden JJ; Dempfle CE; Grobholz R; Fischer CS; Vocke DC; Kiliç R; Sarikoç A; Piñol R; Hagl S; Lang S; Brueckmann M; Borggrefe M
Cardiovasc Pathol; 2005; 14(2):80-7. PubMed ID: 15780799
[TBL] [Abstract][Full Text] [Related]
3. p21WAF1/CIP1 and 14-3-3 sigma gene expression in degenerated aortic valves: a link between cell cycle checkpoints and calcification.
Golubnitschaja O; Yeghiazaryan K; Skowasch D; Schild H; Bauriedel G
Amino Acids; 2006 Oct; 31(3):309-16. PubMed ID: 16953367
[TBL] [Abstract][Full Text] [Related]
4. Expression and activity of matrix metalloproteinase-2 in calcific aortic stenosis.
Kaden JJ; Vocke DC; Fischer CS; Grobholz R; Brueckmann M; Vahl CF; Hagl S; Haase KK; Dempfle CE; Borggrefe M
Z Kardiol; 2004 Feb; 93(2):124-30. PubMed ID: 14963678
[TBL] [Abstract][Full Text] [Related]
5. Extracellular matrix remodelling in human aortic valve disease: the role of matrix metalloproteinases and their tissue inhibitors.
Fondard O; Detaint D; Iung B; Choqueux C; Adle-Biassette H; Jarraya M; Hvass U; Couetil JP; Henin D; Michel JB; Vahanian A; Jacob MP
Eur Heart J; 2005 Jul; 26(13):1333-41. PubMed ID: 15827062
[TBL] [Abstract][Full Text] [Related]
6. Transcription factor Egr-1 in calcific aortic valve disease.
Ghazvini-Boroujerdi M; Clark J; Narula N; Palmatory E; Connolly JM; DeFelice S; Xu J; Jian B; Hazelwood S; Levy RJ
J Heart Valve Dis; 2004 Nov; 13(6):894-903. PubMed ID: 15597579
[TBL] [Abstract][Full Text] [Related]
7. Profile and localization of matrix metalloproteinases (MMPs) and their tissue inhibitors (TIMPs) in human heart valves.
Dreger SA; Taylor PM; Allen SP; Yacoub MH
J Heart Valve Dis; 2002 Nov; 11(6):875-80; discussion 880. PubMed ID: 12479292
[TBL] [Abstract][Full Text] [Related]
8. Differential profile of the OPG/RANKL/RANK-system in degenerative aortic native and bioprosthetic valves.
Steinmetz M; Skowasch D; Wernert N; Welsch U; Preusse CJ; Welz A; Nickenig G; Bauriedel G
J Heart Valve Dis; 2008 Mar; 17(2):187-93. PubMed ID: 18512489
[TBL] [Abstract][Full Text] [Related]
9. Atherosclerotic inflammation triggers osteogenic bone transformation in calcified and stenotic human aortic valves: still a matter of debate.
Anger T; Carson W; Weyand M; Daniel WG; Hoeher M; Garlichs CD
Exp Mol Pathol; 2009 Feb; 86(1):10-7. PubMed ID: 19084515
[TBL] [Abstract][Full Text] [Related]
10. Decalcification of the aortic valve does not prevent early recalcification.
Dahm M; Dohmen G; Groh E; Krummenauer F; Hafner G; Mayer E; Hake U; Oelert H
J Heart Valve Dis; 2000 Jan; 9(1):21-6. PubMed ID: 10678372
[TBL] [Abstract][Full Text] [Related]
11. Refining molecular pathways leading to calcific aortic valve stenosis by studying gene expression profile of normal and calcified stenotic human aortic valves.
Bossé Y; Miqdad A; Fournier D; Pépin A; Pibarot P; Mathieu P
Circ Cardiovasc Genet; 2009 Oct; 2(5):489-98. PubMed ID: 20031625
[TBL] [Abstract][Full Text] [Related]
12. New evidence for a critical role of elastin in calcification of native heart valves: immunohistochemical and ultrastructural study with literature review.
Perrotta I; Russo E; Camastra C; Filice G; Di Mizio G; Colosimo F; Ricci P; Tripepi S; Amorosi A; Triumbari F; Donato G
Histopathology; 2011 Sep; 59(3):504-13. PubMed ID: 22034890
[TBL] [Abstract][Full Text] [Related]
13. Noncollagenous bone matrix proteins as a part of calcific aortic valve disease regulation.
Pohjolainen V; Taskinen P; Soini Y; Rysä J; Ilves M; Juvonen T; Ruskoaho H; Leskinen H; Satta J
Hum Pathol; 2008 Nov; 39(11):1695-701. PubMed ID: 18701137
[TBL] [Abstract][Full Text] [Related]
14. Is the degeneration of aortic valve bioprostheses similar to that of native aortic valves? Insights into valvular pathology.
Skowasch D; Steinmetz M; Nickenig G; Bauriedel G
Expert Rev Med Devices; 2006 Jul; 3(4):453-62. PubMed ID: 16866642
[TBL] [Abstract][Full Text] [Related]
15. Tissue microarray detection of matrix metalloproteinases, in diseased tricuspid and bicuspid aortic valves with or without pathology of the ascending aorta.
Koullias GJ; Korkolis DP; Ravichandran P; Psyrri A; Hatzaras I; Elefteriades JA
Eur J Cardiothorac Surg; 2004 Dec; 26(6):1098-103. PubMed ID: 15541969
[TBL] [Abstract][Full Text] [Related]
16. Do statins slow the process of calcification of aortic tissue valves?
Gilmanov D; Bevilacqua S; Mazzone A; Glauber M
Interact Cardiovasc Thorac Surg; 2010 Sep; 11(3):297-301. PubMed ID: 20570976
[TBL] [Abstract][Full Text] [Related]
17. St Jude Epic heart valve bioprostheses versus native human and porcine aortic valves - comparison of mechanical properties.
Kalejs M; Stradins P; Lacis R; Ozolanta I; Pavars J; Kasyanov V
Interact Cardiovasc Thorac Surg; 2009 May; 8(5):553-6. PubMed ID: 19190025
[TBL] [Abstract][Full Text] [Related]
18. Expression of matrix metalloproteinases and endogenous inhibitors within ascending aortic aneurysms of patients with bicuspid or tricuspid aortic valves.
Ikonomidis JS; Jones JA; Barbour JR; Stroud RE; Clark LL; Kaplan BS; Zeeshan A; Bavaria JE; Gorman JH; Spinale FG; Gorman RC
J Thorac Cardiovasc Surg; 2007 Apr; 133(4):1028-36. PubMed ID: 17382648
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth factor-beta1 mechanisms in aortic valve calcification: increased alkaline phosphatase and related events.
Clark-Greuel JN; Connolly JM; Sorichillo E; Narula NR; Rapoport HS; Mohler ER; Gorman JH; Gorman RC; Levy RJ
Ann Thorac Surg; 2007 Mar; 83(3):946-53. PubMed ID: 17307438
[TBL] [Abstract][Full Text] [Related]
20. Glycosaminoglycan-degrading enzymes in porcine aortic heart valves: implications for bioprosthetic heart valve degeneration.
Simionescu DT; Lovekamp JJ; Vyavahare NR
J Heart Valve Dis; 2003 Mar; 12(2):217-25. PubMed ID: 12701795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
